Molecular diagnostics : for the clinical laboratorian
暂无分享,去创建一个
[1] R. Jones,et al. Immunological Properties of an Antibody Containing a Fluorescent Group.∗ , 1941 .
[2] C. Taylor,et al. The demonstration of plasma cells and other immunoglobulin-containing cells in formalin-fixed, paraffin-embedded tissues using peroxidase-labelled antibody , 1974, Journal of clinical pathology.
[3] S. Huang. Immunohistochemical demonstration of hepatitis B core and surface antigens in paraffin sections. , 1975, Laboratory investigation; a journal of technical methods and pathology.
[4] C. Milstein,et al. Continuous cultures of fused cells secreting antibody of predefined specificity , 1975, Nature.
[5] R. M. Schmidt,et al. Stigmatization of carrier status: social implications of heterozygote genetic screening programs. , 1978, American journal of public health.
[6] C. Marsden,et al. Attitudes of families to some aspects of Huntington's chorea , 1979, Psychological Medicine.
[7] S. Hsu,et al. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[8] P. Harper,et al. Genetic prediction and family structure in Huntington's chorea. , 1985, British medical journal.
[9] C. Croce,et al. Chromosome translocations and human cancer. , 1985, Scientific American.
[10] K. Lennert,et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. , 1985, Blood.
[11] S. J. Bird. Presymptomatic testing for Huntington's disease. , 1985, JAMA.
[12] L. Farrer. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk. , 1986, American journal of medical genetics.
[13] M. Koenig,et al. Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals , 1987, Cell.
[14] A. Monaco,et al. Cloning of the Duchenne/Becker muscular dystrophy locus. , 1988, Advances in human genetics.
[15] K. Klinger,et al. Predictive testing for Huntington's disease with use of a linked DNA marker. , 1988, The New England journal of medicine.
[16] S. Folstein,et al. Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease. , 1989, JAMA.
[17] J. Cassiman,et al. The motivation of at‐risk individuals and their partners in deciding for or against predictive testing for Huntington's disease , 1989, Clinical genetics.
[18] T. Harris,et al. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. , 1989, Journal of immunological methods.
[19] L. Kunkel,et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.
[20] D. Craufurd,et al. UPTAKE OF PRESYMPTOMATIC PREDICTIVE TESTING FOR HUNTINGTON'S DISEASE , 1989, The Lancet.
[21] C R King,et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Ann M. Johnson,et al. Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. , 1990, American journal of medical genetics.
[23] B. Vogelstein,et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.
[24] Kathleen R. Cho,et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.
[25] A. Pestronk,et al. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. , 1991, Archives of neurology.
[26] M. Key,et al. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[27] K. Kinzler,et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.
[28] Margaret Robertson,et al. Identification and characterization of the familial adenomatous polyposis coli gene , 1991, Cell.
[29] K. Kinzler,et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. , 1991, Science.
[30] G. Bruyn,et al. Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. , 1991, Journal of medical genetics.
[31] J. Ervasti,et al. Membrane organization of the dystrophin-glycoprotein complex , 1991, Cell.
[32] A. Yu,et al. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an intergroup rhabdomyosarcoma study project , 1991, Cancer.
[33] J. Phillips,et al. Presymptomatic testing for adult onset polycystic kidney disease in at-risk kidney transplant donors. , 1991, American journal of medical genetics.
[34] S. Altschul,et al. Identification of FAP locus genes from chromosome 5q21. , 1991, Science.
[35] A. Pestronk,et al. Long‐term benefit from prednisone therapy in Duchenne muscular dystrophy , 1991, Neurology.
[36] Joe C. Adams,et al. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[37] G. Wahl,et al. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.
[38] M. Hayden,et al. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk. , 1992, American journal of medical genetics.
[39] T M Grogan,et al. Automated immunohistochemical analysis. , 1992, American journal of clinical pathology.
[40] A. Velázquez,et al. Isolation and characterization of allelic losses and gains in colorectal tumors by arbitrarily primed polymerase chain reaction. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[41] Thea D. Tlsty,et al. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.
[42] W. King,et al. Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. , 1993, Human molecular genetics.
[43] Robin J. Leach,et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer , 1993, Cell.
[44] Darryl Shibata,et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.
[45] M. Hayden,et al. Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene: Relevance for Other Adult-Onset Disorders , 1993 .
[46] D. Bentley,et al. Exon structure of the human dystrophin gene. , 1993, Genomics.
[47] Bert Vogelstein,et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.
[48] S N Thibodeau,et al. Microsatellite instability in cancer of the proximal colon. , 1993, Science.
[49] M. Hollstein,et al. Clinical implications of the p53 tumor-suppressor gene. , 1993, The New England journal of medicine.
[50] N. Copeland,et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. , 1993, Cell.
[51] M. Oren. Relationship of p53 to the control of apoptotic cell death. , 1994, Seminars in cancer biology.
[52] E. Eichler,et al. Length of uninterrupted CGG repeats determines instability in the FMR1 gene , 1994, Nature Genetics.
[53] M. Götz,et al. Utilization of prenatal diagnosis for cystic fibrosis over the past seven years. , 1994, Pediatrics.
[54] A. Bateman,et al. immunocytochemistry: a study of 80 antibodies , 2022 .
[55] Y S Erozan,et al. Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[56] N. Holtzman,et al. Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization. , 1994, American journal of human genetics.
[57] F. Askin,et al. Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. , 1994, Human pathology.
[58] J. Brandt,et al. Self-selection in predictive testing for Huntington's disease. , 1994, American journal of medical genetics.
[59] J. Brandt,et al. Psychological costs and benefits of predictive testing for Huntington's disease. , 1994, American journal of medical genetics.
[60] H. Satoh,et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. , 1994, Blood.
[61] M. Daly,et al. Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] Y. Nakamura,et al. Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. , 1994, Cancer Research.
[63] L. Hartwell,et al. Cell cycle control and cancer. , 1994, Science.
[64] D N Shapiro,et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. , 1994, Science.
[65] T. Triche,et al. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. , 1994, The New England journal of medicine.
[66] M. Modell,et al. The impact of population based screening for carriers of cystic fibrosis. , 1994, Journal of medical genetics.
[67] H Stein,et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.
[68] R. Fleischmann,et al. Mutation of a mutL homolog in hereditary colon cancer. , 1994, Science.
[69] R. Cote,et al. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques , 1994, Human pathology.
[70] L. Augenlicht,et al. Presence and instability of repetitive elements in sequences the altered expression of which characterizes risk for colonic cancer. , 1995, Cancer research.
[71] G. Cattoretti,et al. Antigen Unmasking on Formalin‐Fixed Paraffin‐Embedded Tissues Using Microwaves: A Review , 1995 .
[72] A. Gown,et al. Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood. , 1995, The American journal of pathology.
[73] K. Gatter,et al. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist , 1995 .
[74] S. Thibodeau,et al. Genomic instability in neoplasia. , 1995, Seminars in cell biology.
[75] P. Delrio,et al. Microsatellite instability and pathological aspects of breast cancer , 1995, International journal of cancer.
[76] T. Tlsty,et al. Genomic instability and cancer. , 1995, Mutation research.
[77] K. Kinzler,et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. , 1995, Cancer research.
[78] N. Harris,et al. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. , 1995, American journal of clinical pathology.
[79] J. Lasota,et al. Bcl‐2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B‐cell proliferations is of diagnostic value , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[80] P. Modrich,et al. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[81] M. Mori,et al. Microsatellite instability in multiple gastric cancers , 1995, International journal of cancer.
[82] Asad Umar,et al. A hPMS2 Mutant Cell Line Is Defective in Strand-specific Mismatch Repair (*) , 1995, The Journal of Biological Chemistry.
[83] R I Richards,et al. Simple tandem DNA repeats and human genetic disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[84] M. Hayden,et al. Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes. , 1995, American journal of human genetics.
[85] C. Boland,et al. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. , 1995, Journal of the National Cancer Institute.
[86] R. Zarbo,et al. Evaluation of anti-p53 antibody staining immunoreactivity in benign tumors and nonneoplastic tissues , 1995 .
[87] B. Trock,et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. , 1996, JAMA.
[88] F. Niggli,et al. Detection of t(11;22)(q24;ql2) Translocation Breakpoint in Paraffin‐embedded Tissue of the Ewing's Sarcoma Family by Nested Reverse Transcription‐Polymerase Chain Reaction , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[89] T. Iwama,et al. Frequent Microsatellite Instabilities and Analyses of the Related Genes in Familial Gastric Cancers , 1996, Japanese journal of cancer research : Gann.
[90] G. Petersen,et al. Genetic testing and counseling in familial adenomatous polyposis. , 1996, Oncology.
[91] R. Benezra,et al. Identification of a Human Mitotic Checkpoint Gene: hsMAD2 , 1996, Science.
[92] C. Harris,et al. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. , 1996, Journal of the National Cancer Institute.
[93] T. Kunkel,et al. Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair , 1996, Nature Genetics.
[94] G. Wahl,et al. Microsatellite instability correlates with reduced survival and poor disease prognosis in breast cancer. , 1996, Cancer research.
[95] J. Rüschoff,et al. GENOMIC INSTABILITY IN COLORECTAL CARCINOMAS: COMPARISON OF DIFFERENT EVALUATION METHODS AND THEIR BIOLOGICAL SIGNIFICANCE , 1996, The Journal of pathology.
[96] T. Hansen,et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.
[97] M. Pignatelli,et al. The molecular histology of neoplasia: the role of the cadherin/catenin complex , 1997, Histopathology.
[98] L. Shaffer,et al. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. , 1997, American journal of medical genetics.
[99] R. Cote,et al. Immunohistochemical markers of prognostic value in surgical pathology. , 1997, Histology and histopathology.
[100] J. Gebert,et al. Microsatellite instability analysis: a multicenter study for reliability and quality control. , 1997, Cancer research.
[101] I. Moore,et al. Immunohistochemical detection of the Wilms’ tumour gene WT1 in desmoplastic small round cell tumour , 1997, Histopathology.
[102] H. Ackermann,et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.
[103] G. Bell,et al. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. , 1997, Nature genetics.
[104] R. Cote,et al. Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[105] J. Rüschoff,et al. Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. , 1997, Cancer research.
[106] W. Chan,et al. Clonality in nodular lymphocyte-predominant Hodgkin's disease. , 1997, The New England journal of medicine.
[107] P. Peltomäki. DNA mismatch repair gene mutations in human cancer. , 1997, Environmental health perspectives.
[108] R. Alsabeh,et al. Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease: a paraffin-section immunohistochemical study using the heat-induced epitope retrieval method. , 1997, American journal of clinical pathology.
[109] R. Turner,et al. Mutations in the Hepatocyte Nuclear Factor-1α Gene in MODY and Early-Onset NIDDM: Evidence for a Mutational Hotspot in Exon 4 , 1997, Diabetes.
[110] T. Kunkel,et al. Mismatch repair in extracts of Werner syndrome cell lines. , 1997, Cancer research.
[111] R. Mariani-Costantini,et al. Microsatellite instability is correlated with lymph node-positive breast cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[112] R. Croyle,et al. Genetic counseling issues , 1997 .
[113] G. Thomas,et al. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. , 1997, Cancer research.
[114] William L. Clarke,et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence , 1997, Nature Genetics.
[115] W. Clarke,et al. Early-onset type-ll diabetes mellitus (MODY4) linked to IPF1 , 1997, Nature Genetics.
[116] Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. , 1997 .
[117] M. MacDonald,et al. Reduced penetrance of the Huntington's disease mutation. , 1997, Human molecular genetics.
[118] S. Bundey. Few psychological consequences of presymptomatic testing for Huntington disease , 1997, The Lancet.
[119] B. Devellis,et al. Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. , 1997, American journal of medical genetics.
[120] T. McIntosh,et al. The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. , 1998, The Journal of clinical investigation.
[121] A. Middleton,et al. Attitudes of deaf adults toward genetic testing for hereditary deafness. , 1998, American journal of human genetics.
[122] Jian Kuang,et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.
[123] N. Ordóñez. Desmoplastic small round cell tumor: II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. , 1998, The American journal of surgical pathology.
[124] D. Schaid,et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.
[125] J. Takeda,et al. Frameshift Mutation, A263fsinsGG, in the Hepatocyte Nuclear Factor-1β Gene Associated With Diabetes and Renal Dysfunction , 1998, Diabetes.
[126] T. Kunkel,et al. Characterization of Distinct Human Endometrial Carcinoma Cell Lines Deficient in Mismatch Repair That Originated from a Single Tumor* , 1998, The Journal of Biological Chemistry.
[127] W. Gerald,et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] S. Schwartz,et al. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53 , 1998, Oncogene.
[129] K. Hoang-Xuan,et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites , 1998, Genes, chromosomes & cancer.
[130] S. Pileri,et al. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. , 1998, Journal of clinical pathology.
[131] K. Aldape,et al. An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[132] M. Vyberg,et al. Dextran Polymer Conjugate Two-Step Visualization System for Immunohistochemistry: A Comparison of EnVision+ With Two Three-Step Avidin-Biotin Techniques , 1998 .
[133] N. Holtzman,et al. Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women? , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[134] V. Golubovskaya,et al. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein , 1998, Oncogene.
[135] Christine Yoshinaga-Itano,et al. Language of Early- and Later-identified Children With Hearing Loss , 1998, Pediatrics.
[136] S. Hirota,et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. , 1998, Science.
[137] R. Croyle,et al. The new genetics: Psychological responses to genetic testing , 1998 .
[138] A Truchaud,et al. Comparative evaluation of automated systems in immunohistochemistry. , 1998, Clinica chimica acta; international journal of clinical chemistry.
[139] C. Canman,et al. The role of ATM in DNA damage responses and cancer , 1998, Oncogene.
[140] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[141] Rotterdam,et al. Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup. , 1998, Journal of medical genetics.
[142] Hongbing Zhang,et al. BRCA1, BRCA2, and DNA Damage Response: Collision or Collusion? , 1998, Cell.
[143] B. Vogelstein,et al. Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences. , 1998, The American journal of pathology.
[144] Chan,et al. Immunostaining for cyclin D1 and the diagnosis of mantle cell lymphoma: is there a reliable method? , 1999, Histopathology.
[145] C. Amos,et al. Loci for efficient detection of microsatellite instability in hereditary non-polyposis colorectal cancer. , 1999, Oncology reports.
[146] Y. Shiratori,et al. Mutational Inactivation of Mitotic Checkpoint Genes, hsMAD2 and hBUB1, Is Rare in Sporadic Digestive Tract Cancers , 1999, Japanese journal of cancer research : Gann.
[147] A. Ashworth,et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification , 1999, Current Biology.
[148] H. Mori,et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. , 1999, Cancer research.
[149] Patrick E Carroll,et al. Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression , 1999, Oncogene.
[150] T. Bird. Outrageous fortune: the risk of suicide in genetic testing for Huntington disease. , 1999, American journal of human genetics.
[151] V. Sheffield,et al. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. , 1999, JAMA.
[152] Clive R. Taylor,et al. Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry , 1999 .
[153] Z. Cohen,et al. Negative genetic test result in familial adenomatous polyposis , 1999, Diseases of the colon and rectum.
[154] J. Allanson,et al. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer , 1999, Clinical genetics.
[155] A. Gown,et al. Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[156] G Flandrin,et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[157] K. Kinzler,et al. Characterization of MAD2B and other mitotic spindle checkpoint genes. , 1999, Genomics.
[158] D. Bowen,et al. Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[159] M. Kinney. The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T-cell or NK-cell neoplasms. , 1999, American journal of clinical pathology.
[160] M. Hayden,et al. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. , 1999, American journal of human genetics.
[161] J. Jen,et al. Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines. , 1999, Cancer letters.
[162] M. Eguchi,et al. Defective control of apoptosis and mitotic spindle checkpoint in heterozygous carriers of ATM mutations. , 1999, Cancer research.
[163] Paul J. Kurtin,et al. Demonstration of distinct antigenic profiles of small B-cell lymphomas by paraffin section immunohistochemistry. , 1999, American journal of clinical pathology.
[164] E. Campo,et al. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. , 1999, Blood.
[165] K. Glanz,et al. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[166] L. Tiret,et al. Characterization of a Unique Genetic Variant in the β1-adrenoceptor Gene and Evaluation of its Role in Idiopathic Dilated Cardiomyopathy , 1999 .
[167] Salma K. Marani,et al. Intention to learn results of genetic testing for hereditary colon cancer. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[168] R. Cartun. Use of Immunohistochemistry in the Surgical Pathology Laboratory for the Diagnosis of Infectious Diseases , 1999 .
[169] W. McKellin,et al. ‘There’s this thing in our family’: predictive testing and the construction of risk for Huntington Disease , 1999 .
[170] J. Nährig,et al. Protocol for ultrarapid immunostaining of frozen sections. , 1999, Journal of clinical pathology.
[171] Keizo Sugimachi,et al. Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair , 1999, Oncogene.
[172] J.. Diagnostic Immunohistochemistry , 2022 .